(CRWD) Crowdstrike Holdings - Ratings and Ratios
Endpoint Security, Cloud Workload, Identity Protection, Threat Intelligence
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 42.8% |
| Value at Risk 5%th | 68.1% |
| Relative Tail Risk | -3.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.85 |
| Alpha | 25.47 |
| CAGR/Max DD | 1.49 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.363 |
| Beta | 1.547 |
| Beta Downside | 1.263 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.44% |
| Mean DD | 8.65% |
| Median DD | 5.69% |
Description: CRWD Crowdstrike Holdings December 02, 2025
CrowdStrike Holdings, Inc. (NASDAQ: CRWD) delivers a cloud-native, SaaS-based security platform-Falcon-that protects endpoints, cloud workloads, identities, and data. Its unified offering bundles endpoint detection and response, workload security, vulnerability management, identity protection, threat intelligence, security-orchestration-automation-response (SOAR), and security-information-and-event-management (SIEM) capabilities, all sold primarily through subscription contracts.
Key recent metrics: FY 2023 revenue reached approximately $2.2 billion, up about 33 % year-over-year, and the company reported a subscription annual recurring revenue (ARR) of roughly $6.5 billion. The broader cybersecurity market is expanding at a compound annual growth rate of ~10 % driven by escalating ransomware incidents and the migration of enterprise workloads to public cloud environments-trends that directly boost demand for CrowdStrike’s cloud-first solutions.
For a deeper quantitative view, you might explore ValueRay’s analyst tools to see how these drivers translate into forward-looking valuation scenarios.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-314.2m TTM) > 0 and > 6% of Revenue (6% = 273.9m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA -2.54pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 63.95% (prev 60.89%; Δ 3.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 1.46b > Net Income -314.2m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (251.3m) change vs 12m ago 2.36% (target <= -2.0% for YES) |
| Gross Margin 74.13% (prev 75.24%; Δ -1.12pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.44% (prev 48.06%; Δ 3.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -6.92 (EBITDA TTM -67.7m / Interest Expense TTM 27.1m) >= 6 (WARN >= 3) |
Altman Z'' 1.12
| (A) 0.29 = (Total Current Assets 6.52b - Total Current Liabilities 3.60b) / Total Assets 9.97b |
| (B) -0.13 = Retained Earnings (Balance) -1.30b / Total Assets 9.97b |
| (C) -0.02 = EBIT TTM -187.8m / Avg Total Assets 8.87b |
| (D) -0.22 = Book Value of Equity -1.30b / Total Liabilities 5.91b |
| Total Rating: 1.12 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.64
| 1. Piotroski 3.0pt |
| 2. FCF Yield 0.93% |
| 3. FCF Margin 25.31% |
| 4. Debt/Equity 0.20 |
| 5. Debt/Ebitda 58.81 |
| 6. ROIC - WACC (= -17.92)% |
| 7. RoE -8.66% |
| 8. Rev. Trend 98.85% |
| 9. EPS Trend 87.95% |
What is the price of CRWD shares?
Over the past week, the price has changed by -1.42%, over one month by -7.53%, over three months by +15.75% and over the past year by +38.11%.
Is CRWD a buy, sell or hold?
- Strong Buy: 27
- Buy: 12
- Hold: 11
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CRWD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 549.5 | 8.9% |
| Analysts Target Price | 549.5 | 8.9% |
| ValueRay Target Price | 700.1 | 38.7% |
CRWD Fundamental Data Overview December 06, 2025
P/E Forward = 108.6957
P/S = 28.2071
P/B = 32.7507
P/EG = 4.35
Beta = 1.094
Revenue TTM = 4.57b USD
EBIT TTM = -187.8m USD
EBITDA TTM = -67.7m USD
Long Term Debt = 745.1m USD (from longTermDebt, last quarter)
Short Term Debt = 15.9m USD (from shortTermDebt, last quarter)
Debt = 818.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.98b USD (from netDebt column, last quarter)
Enterprise Value = 124.79b USD (128.77b + Debt 818.0m - CCE 4.80b)
Interest Coverage Ratio = -6.92 (Ebit TTM -187.8m / Interest Expense TTM 27.1m)
FCF Yield = 0.93% (FCF TTM 1.16b / Enterprise Value 124.79b)
FCF Margin = 25.31% (FCF TTM 1.16b / Revenue TTM 4.57b)
Net Margin = -6.88% (Net Income TTM -314.2m / Revenue TTM 4.57b)
Gross Margin = 74.13% ((Revenue TTM 4.57b - Cost of Revenue TTM 1.18b) / Revenue TTM)
Gross Margin QoQ = 75.06% (prev 73.46%)
Tobins Q-Ratio = 12.52 (Enterprise Value 124.79b / Total Assets 9.97b)
Interest Expense / Debt = 0.85% (Interest Expense 6.93m / Debt 818.0m)
Taxrate = -46.07% (negative due to tax credits) (10.7m / -23.3m)
NOPAT = -274.4m (EBIT -187.8m * (1 - -46.07%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.81 (Total Current Assets 6.52b / Total Current Liabilities 3.60b)
Debt / Equity = 0.20 (Debt 818.0m / totalStockholderEquity, last quarter 4.02b)
Debt / EBITDA = 58.81 (negative EBITDA) (Net Debt -3.98b / EBITDA -67.7m)
Debt / FCF = -3.45 (Net Debt -3.98b / FCF TTM 1.16b)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.15% (Net Income -314.2m / Total Assets 9.97b)
RoE = -8.66% (Net Income TTM -314.2m / Total Stockholder Equity 3.63b)
RoCE = -4.30% (EBIT -187.8m / Capital Employed (Equity 3.63b + L.T.Debt 745.1m))
RoIC = -6.28% (negative operating profit) (NOPAT -274.4m / Invested Capital 4.37b)
WACC = 11.64% (E(128.77b)/V(129.59b) * Re(11.71%) + D(818.0m)/V(129.59b) * Rd(0.85%) * (1-Tc(-0.46)))
Discount Rate = 11.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.53%
[DCF Debug] Terminal Value 70.45% ; FCFE base≈1.13b ; Y1≈1.40b ; Y5≈2.39b
Fair Price DCF = 91.72 (DCF Value 23.02b / Shares Outstanding 251.0m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 87.95 | EPS CAGR: 36.37% | SUE: 0.48 | # QB: 0
Revenue Correlation: 98.85 | Revenue CAGR: 32.39% | SUE: 1.85 | # QB: 2
EPS next Quarter (2026-04-30): EPS=1.06 | Chg30d=+0.012 | Revisions Net=+0 | Analysts=40
EPS next Year (2027-01-31): EPS=4.83 | Chg30d=+0.025 | Revisions Net=+1 | Growth EPS=+29.9% | Growth Revenue=+22.0%
Additional Sources for CRWD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle